📍 Whitefield, Bengaluru
HOD & Senior Consultant · Surgical Oncology
Consultation by Appointment
A diagnosis of head and neck cancer brings many questions at once. This guide covers mouth cancer (oral cancer), throat cancer, tongue cancer, HPV-related oropharyngeal cancer, laryngeal (voice box) cancer, nasopharyngeal cancer, sinus cancer, and salivary gland cancer. Many of these cancers are highly treatable, and early diagnosis offers the best chance of cure.
Head and neck cancer is usually managed by a team that may include surgical, radiation and medical oncologists, reconstructive surgeons, speech and swallowing therapists, dietitians and counselors. In each section below, the questions patients ask most often appear first.
About the statistics in this guide: Survival and incidence figures are population estimates, mostly from the U.S. National Cancer Institute (SEER) and international cancer registries. They reflect people treated in past years and cannot predict any individual outcome. Your oncologist can explain what the numbers mean for you.
Jump to: Understanding your diagnosis | Symptoms | Causes and HPV | Diagnosis and testing | Staging and survival | Treatment options | Side effects | Eating, speech and appearance | Life after treatment | Support and costs | Prevention and HPV vaccination | When to contact your team
Many head and neck cancers can be cured, especially when found at an early stage. Cure is also the treatment goal for most cancers that have not spread beyond the head and neck.
| Stage group | Treatment goal | Typical approach |
|---|---|---|
| Stage I–II (early) | Cure | Single treatment: surgery OR radiation |
| Stage III–IVB (locally advanced) | Cure | Combined treatment: surgery + radiation ± chemotherapy, or chemoradiation |
| Stage IVC (distant spread) | Disease control, longer life, symptom relief | Immunotherapy, chemotherapy, targeted therapy, clinical trials |
Head and neck cancer is a group of cancers that begin in the mouth, throat, voice box, nose, sinuses, or salivary glands. About 90% are squamous cell carcinomas, which start in the thin lining cells of these areas.
| Type of cancer | Where it starts | Examples |
|---|---|---|
| Oral cavity cancer (mouth cancer) | Lips, front two-thirds of tongue, gums, floor of mouth, cheek lining, hard palate | Tongue cancer, gum cancer, cheek cancer |
| Oropharyngeal cancer (throat cancer) | Middle of the throat: base of tongue, tonsils, soft palate | Tonsil cancer, HPV-positive throat cancer |
| Laryngeal cancer | Voice box (larynx), including the vocal cords | Vocal cord cancer, glottic cancer |
| Hypopharyngeal cancer | Lower throat, behind and beside the voice box | Pyriform sinus cancer |
| Nasopharyngeal cancer | Upper throat, behind the nose | EBV-related nasopharyngeal carcinoma |
| Nasal cavity and paranasal sinus cancer | Inside the nose and the air spaces around it | Maxillary sinus cancer |
| Salivary gland cancer | Parotid, submandibular, and minor salivary glands | Mucoepidermoid, adenoid cystic carcinoma |
The site, cell type, and HPV status of your cancer help determine your stage, treatment plan, likely side effects, and outlook.
Head and neck cancer accounts for roughly 4% of cancers in the United States and ranks among the most common cancers worldwide.
Many head and neck cancers grow over weeks to months. They typically spread first to lymph nodes in the neck, and less often to distant organs such as the lungs.
Common early signs of head and neck cancer include a mouth sore that does not heal, a persistent sore throat, a painless neck lump, and hoarseness lasting more than three weeks.
| Symptom | Possible cancer site |
|---|---|
| Mouth ulcer, red or white patch lasting over 3 weeks | Oral cavity (mouth, tongue, gums) |
| Painless lump in the neck | Oropharynx, nasopharynx, or another site spreading to lymph nodes |
| Hoarseness or voice change lasting over 3 weeks | Larynx (voice box) |
| Persistent sore throat or feeling of something stuck | Oropharynx, hypopharynx |
| Difficulty or pain with swallowing | Oropharynx, hypopharynx, larynx |
| One-sided ear pain with a normal ear exam | Throat, tongue base, larynx |
| One-sided nasal blockage, nosebleeds, or ear fullness | Nasal cavity, sinuses, nasopharynx |
| Swelling in front of the ear or under the jaw; facial weakness | Salivary glands |
| Loose teeth or dentures that no longer fit | Gums, jaw, sinuses |
| Unexplained weight loss; coughing up blood | Possible advanced disease |
These symptoms often have non-cancer causes. Persistence beyond three weeks is the key signal to see a specialist.
A painless neck lump that lasts longer than two to three weeks in an adult can be a sign of head and neck cancer, especially HPV-related throat cancer, and should be evaluated by a specialist.
Yes, this is common. Early head and neck cancer symptoms can resemble tonsillitis, acid reflux, dental problems, or sinus infections, which can delay diagnosis.
Most head and neck cancers are linked to tobacco use, heavy alcohol use, or infection with high-risk human papillomavirus (HPV). Many patients have more than one risk factor, and some have none that can be identified.
| Risk factor | How it raises risk |
|---|---|
| Tobacco (cigarettes, cigars, pipes, bidis, chewing tobacco, snuff) | Leading cause of mouth, larynx, and hypopharynx cancers; risk rises with amount and years of use |
| Alcohol | Heavy drinking raises risk; combined with smoking, risk increases far more than either alone |
| HPV infection (mainly HPV-16) | Main cause of oropharyngeal (tonsil and tongue base) cancer in many countries |
| Betel quid, areca nut, gutka, paan | Major cause of oral cancer in South and Southeast Asia |
| Epstein-Barr virus (EBV) | Linked to nasopharyngeal cancer |
| Age over 50 and male sex | Higher incidence; HPV-related cancers often appear in people in their 40s and 50s |
| Weakened immune system | Higher risk after organ transplant or with HIV |
| Occupational exposures | Wood dust, nickel, formaldehyde, and asbestos are linked to sinus and larynx cancers |
| Prior radiation to the head and neck | Associated with salivary gland and other cancers |
If you have never smoked or drunk heavily, a throat (oropharyngeal) cancer is most likely linked to HPV. In the United States, HPV is estimated to cause about 70% of oropharyngeal cancers.
Cancer itself cannot be passed from one person to another. Current evidence suggests that long-term partners of people with HPV-positive throat cancer do not have a substantially increased risk of developing throat cancer.
Head and neck cancer is rarely inherited. Most cases are linked to tobacco, alcohol, and viral infections rather than genes passed down in families.
Diagnosing and staging head and neck cancer typically involves a specialist exam with a scope, a biopsy, and imaging such as CT, MRI, or PET-CT to show where the cancer is and whether it has spread.
| Step | Test | Purpose | Typical time needed |
|---|---|---|---|
| 1 | Head and neck exam and flexible endoscopy | A thin camera through the nose shows the throat and voice box | 15–30 minutes, in clinic |
| 2 | Biopsy or fine-needle aspiration (FNA) | Confirms cancer and identifies the cell type | FNA: 15–30 min; results in about 3–7 days |
| 3 | Biomarker testing (p16/HPV, EBV, PD-L1 CPS) | Guides staging, outlook, and immunotherapy eligibility | Run on biopsy tissue; about 1–2 weeks |
| 4 | CT and/or MRI with contrast | Shows tumor size, depth, and lymph node involvement | 30–60 minutes |
| 5 | PET-CT scan | Checks for spread to lymph nodes or distant organs | 2–3 hours including preparation |
| 6 | Examination under anesthesia (when needed) | Maps the tumor and checks for a second cancer | Day procedure |
| 7 | Pre-treatment dental, nutrition, and swallowing assessments | Prepares you for treatment and reduces complications | 1–2 weeks, often in parallel |
Times vary by hospital and are provided as general guidance.
p16 testing is a laboratory test on your biopsy that indicates whether an oropharyngeal cancer is HPV-related. A positive result is generally associated with a more favorable outlook and uses a different staging system.
The PD-L1 combined positive score (CPS) measures a protein on tumor and immune cells. It helps predict how likely you are to benefit from immunotherapy such as pembrolizumab.
A second opinion at an experienced head and neck cancer center is generally reasonable, and most oncologists support it.
| Item | Why it is needed |
|---|---|
| Biopsy pathology report | Confirms diagnosis and cell type |
| Pathology slides or tissue blocks (requested from the lab) | Allows independent review by a pathologist |
| CT, MRI, and PET-CT images on disc or via image link, plus reports | Allows a radiologist to review staging |
| Biomarker results (p16/HPV, EBV, PD-L1) | Guides treatment options |
| List of current medicines and allergies | Ensures safe treatment planning |
| Insurance or payer details and photo ID | Speeds registration and pre-authorization |
| Written list of your questions; a family member or friend | Helps you remember and record the discussion |
In the United States, the five-year relative survival rate for cancers of the mouth and throat is approximately 69% overall, and approximately 87% when the cancer is found before it has spread beyond its original site.
| Cancer type | Localized | Regional (lymph nodes) | Distant spread | All stages |
|---|---|---|---|---|
| Oral cavity and pharynx | ~87% | ~70% | ~40% | ~69% |
| Larynx (voice box) | ~78% | ~47% | ~31% | ~62% |
Head and neck cancer is staged from I to IV using the TNM system, which describes tumor size (T), lymph node spread (N), and distant spread (M).
| Component | What it measures | Range |
|---|---|---|
| T (tumor) | Size of the primary tumor and invasion of nearby structures | T1 (small) to T4 (large or invading nearby tissue) |
| N (nodes) | Number, size, and side of neck lymph nodes with cancer | N0 (none) to N3 (large or extensive) |
| M (metastasis) | Spread to distant organs such as lungs, liver, or bone | M0 (none) or M1 (present) |
Prognosis depends mainly on cancer stage, HPV status, tumor site, smoking history, overall health, and how well the cancer responds to treatment.
The main treatments are surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. They are used alone or in combination, depending on cancer site, stage, and your overall health.
| Treatment | How it works | Typically used for |
|---|---|---|
| Surgery | Removes the tumor and nearby lymph nodes (neck dissection) | Oral cavity, early laryngeal, selected throat, and salivary gland cancers |
| Transoral robotic or laser surgery (TORS/TLM) | Removes tumors through the mouth without an external incision | Selected early oropharyngeal and laryngeal cancers |
| Radiation therapy (IMRT, proton therapy) | Focused beams destroy cancer cells while limiting dose to healthy tissue | Primary treatment or after surgery |
| Chemoradiation | Chemotherapy (commonly cisplatin) given with radiation to increase its effect | Locally advanced cancers; larynx preservation |
| Immunotherapy (pembrolizumab, nivolumab) | Helps the immune system recognize and attack cancer | Recurrent or metastatic disease; selected earlier-stage settings |
| Targeted therapy (cetuximab) | Blocks the EGFR protein that drives cancer growth | With radiation when cisplatin is unsuitable, or advanced disease |
| Clinical trials | Access to new treatments and approaches | Any stage, if eligible |
Treatment plans are best made by a multidisciplinary tumor board, where surgeons, radiation oncologists, medical oncologists, radiologists, and pathologists review your case together.
The team weighs these factors, then discusses the options with you:
Head and neck cancer surgery removes the tumor with a margin of healthy tissue, often with a neck dissection to remove lymph nodes. Reconstruction is usually done during the same operation when needed.
| Procedure | Typical hospital stay | Return to light activity | Notes |
|---|---|---|---|
| Transoral laser or robotic surgery (TORS) | 1–3 days | 2–3 weeks | Soft diet initially; throat pain for 2–3 weeks |
| Neck dissection | 1–3 days | 2–3 weeks | Surgical drain for a few days; shoulder exercises |
| Partial glossectomy (small) | 1–3 days | 2–3 weeks | Speech therapy as needed |
| Major resection with free flap reconstruction | 7–14 days | 6–8 weeks or longer | May include temporary tracheostomy and feeding tube |
| Total laryngectomy | 10–14 days | 6–8 weeks or longer | Voice rehabilitation and stoma care training |
| Parotidectomy | 1–2 days | 1–2 weeks | Facial nerve function monitored |
Ranges are typical estimates; your surgeon will give you a personalized recovery plan.
Radiation for head and neck cancer is usually given once a day, five days a week, for about six to seven weeks, using precise techniques such as IMRT or proton therapy.
| Item | Typical detail |
|---|---|
| Mask fitting and CT simulation | One visit, about 1–2 hours |
| Planning period before first treatment | About 1–2 weeks |
| Treatment frequency | Once daily, Monday to Friday |
| Total number of treatments | Commonly 30–35 (curative); fewer for some early laryngeal cancers |
| Total duration | About 6–7 weeks |
| Time on the treatment table | About 15–30 minutes per session |
| Doctor review visits | Once a week during treatment |
| Peak side effects | Final 2 weeks of treatment and 1–2 weeks after |
Chemotherapy is commonly given with radiation for locally advanced head and neck cancer. Cisplatin is the most widely used and best-studied drug in this setting.
| Drug or regimen | Typical schedule | Where given | Typically used |
|---|---|---|---|
| Cisplatin (with radiation) | Every 3 weeks (2–3 doses) or weekly during radiation | Day-care infusion; 2–4 hours with fluids | Standard radiation sensitizer |
| Carboplatin + paclitaxel or 5-FU | Weekly or every 3 weeks | Day-care infusion | When cisplatin is unsuitable |
| TPF (docetaxel, cisplatin, 5-FU) | 2–3 cycles, every 3 weeks, before radiation | Infusion; 5-FU may run via pump | Induction in selected cases |
| Cetuximab | Weekly or every 2 weeks | Day-care infusion; 1–2 hours | With radiation or chemotherapy |
Yes, for many patients. Pembrolizumab and nivolumab are standard options for recurrent or metastatic head and neck cancer, and pembrolizumab is also approved in the U.S. for use around surgery in certain resectable, locally advanced cancers.
| Drug | Infusion frequency | Infusion time | Typical maximum duration |
|---|---|---|---|
| Pembrolizumab | Every 3 or 6 weeks | About 30 minutes | Up to about 2 years, or until progression or side effects |
| Nivolumab | Every 2 or 4 weeks | About 30 minutes | Until progression or side effects |
Curative treatment for head and neck cancer typically takes about two to four months from diagnosis to the end of active treatment, followed by several weeks to months of recovery.
| Phase | Typical duration |
|---|---|
| Diagnosis, staging, and tumor board review | 2–4 weeks |
| Dental care and pre-treatment preparation | 1–2 weeks (often overlapping) |
| Surgery and initial recovery (if needed) | 2–6 weeks |
| Radiation or chemoradiation | 6–7 weeks |
| Recovery from acute side effects | 4–8 weeks after radiation ends |
| First response scan (PET-CT) | About 12 weeks after radiation |
Clinical trials may be an option at any stage of head and neck cancer and offer access to new treatments under close medical supervision.
Many patients can work during diagnosis and the early weeks of treatment. Most need time off during the second half of radiation and for several weeks afterward.
Common side effects include mouth sores, dry mouth, taste changes, difficulty swallowing, skin irritation, and fatigue. Most can be reduced with early, proactive supportive care.
| Side effect | When it usually occurs | How it is managed |
|---|---|---|
| Mouth and throat sores (mucositis) | From weeks 2–3 of radiation; peaks near the end | Pain medicines, numbing rinses, salt and baking soda rinses |
| Dry mouth (xerostomia) | During radiation; may be long-term | Salivary-sparing radiation, saliva substitutes, frequent sips of water, humidifier |
| Taste changes or loss | During radiation | Often improves over 3–12 months |
| Difficulty swallowing (dysphagia) | During and after treatment | Swallowing exercises, speech-language therapy, feeding tube if needed |
| Skin redness and peeling on the neck | Weeks 3–6 of radiation | Prescribed creams, gentle skin care, sun protection |
| Fatigue | Throughout treatment | Light exercise, rest, treating anemia or low thyroid |
| Nausea; kidney and hearing effects | With cisplatin | Anti-nausea medicines, IV fluids, hearing tests |
| Neck swelling (lymphedema) and stiffness (fibrosis) | Months after treatment | Lymphedema therapy, massage, stretching |
| Underactive thyroid (hypothyroidism) | Months to years after neck radiation | Regular TSH blood tests; thyroid medication if needed |
Radiation causes hair loss only in the treated area, so most patients lose beard or neck hair rather than scalp hair.
Dry mouth often improves gradually over one to two years, but some dryness may be permanent, depending on the radiation dose your salivary glands received.
A dental evaluation before radiation is strongly recommended, because radiation increases the long-term risk of tooth decay and a serious jaw bone complication called osteoradionecrosis.
Most patients return to eating by mouth after treatment, although many need to adjust food textures and some have long-term swallowing changes.
Some patients need a temporary feeding tube (PEG or G-tube) to maintain nutrition during or after treatment. In most cases it is removed once they can eat enough by mouth.
Maintaining weight and protein intake during treatment is important, because significant weight loss can lead to treatment breaks, infections, and slower recovery.
Many patients keep their natural voice. Most patients who need a total laryngectomy (voice box removal) can learn to speak again with a voice prosthesis or other methods.
Many modern treatments cause little visible change. When major surgery is needed, reconstruction aims to restore both appearance and function.
A PET-CT scan about 12 weeks after radiation is the most commonly used test to check whether head and neck cancer has responded completely.
Follow-up visits are most frequent in the first two years after treatment, when most recurrences occur, and generally continue for at least five years.
| Time after treatment | Typical visit frequency | What usually happens |
|---|---|---|
| Year 1 | Every 1–3 months | Exam with scope; first PET-CT at about 3 months |
| Year 2 | Every 2–6 months | Exam with scope; imaging as needed |
| Years 3–5 | Every 4–8 months | Exam; imaging if symptoms |
| After 5 years | Once a year | Survivorship visit |
| Thyroid blood test (TSH) | Every 6–12 months if the neck was radiated | Checks for underactive thyroid |
| Dental check | Every 3–6 months long-term | Prevents decay and jaw complications |
The risk of recurrence depends on your stage and HPV status. Most recurrences occur within the first two to three years after treatment.
Recurrent head and neck cancer can still be treated, and some recurrences can be cured with further surgery or radiation.
Head and neck cancer survivors, especially those with a smoking history, have a higher risk of a second cancer in the head and neck, lungs, or esophagus.
Yes, stopping is strongly recommended. Quitting smoking is associated with better treatment response, fewer complications, lower risk of recurrence and second cancers, and longer survival.
Yes. Head and neck cancer patients report higher rates of anxiety and depression than many other cancer patients, and emotional support is an important part of treatment.
Costs vary widely by treatment plan, hospital, and insurance. Many insurance plans and government health schemes cover head and neck cancer treatment, and the hospital’s financial counselor can provide an estimate before treatment begins.
| Service | What it helps with |
|---|---|
| Nurse navigator | Scheduling, coordination, first point of contact |
| Financial counselor | Cost estimates, insurance, assistance programs |
| Oncology dietitian | Nutrition plans, weight maintenance, tube feeding |
| Speech-language pathologist | Swallowing and voice therapy |
| Psycho-oncology / counseling | Anxiety, depression, coping |
| Tobacco cessation program | Counseling and medicines to quit |
| Social worker | Leave paperwork, travel, lodging |
Ask your care team which of these services are available at your hospital.
Asking focused questions at your first visit helps you understand your diagnosis and take an active role in treatment decisions.
Many head and neck cancers can be prevented, or their risk greatly reduced, by avoiding tobacco and areca nut, limiting alcohol, and getting the HPV vaccine.
HPV vaccination is recommended for children and adolescents in many countries and protects against the HPV types that cause most HPV-related throat cancers.
| Age group | Recommendation |
|---|---|
| 9–14 years | Routine vaccination (typically ages 11–12); can start at 9 |
| 15–26 years | Catch-up vaccination if not vaccinated earlier |
| 27–45 years | Shared decision with your doctor |
There is no routine screening test for head and neck cancer in the general population. Family members should know the warning signs and have regular dental and medical checkups.
Seek emergency help straight away for breathing difficulty, heavy bleeding, chest pain or sudden confusion, and call your oncology team the same day for the other problems listed below.
| Symptom | What to do |
|---|---|
| Difficulty breathing, noisy breathing, or a blocked tracheostomy | Call your local emergency number immediately |
| Heavy bleeding from the mouth, throat, neck, or stoma | Call your local emergency number immediately |
| Chest pain or sudden confusion | Call your local emergency number immediately |
| Fever of 38°C (100.4°F) or higher during chemotherapy | Call your oncology team the same day |
| Unable to swallow liquids or keep medicines down | Call your oncology team the same day |
| Signs of dehydration (dizziness, very little urine) | Call your oncology team the same day |
| Pain not controlled by prescribed medicine | Call your oncology team the same day |
| Feeding tube has come out | Call your oncology team the same day |
| New lump, ear pain, or voice change after treatment | Call to book a visit within 1–2 weeks |
